VRS
CLVS

Virginia Retirement Systems’s Clovis Oncology, Inc. CLVS Stock Holding History

Virginia Retirement Systems’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,500
Closed -$45 – 1247
2021
Q4 		$45 Sell
16,500
-14,300
-46% -$52.9K ﹤0.01% 1097
2021
Q3 		$137K Sell
30,800
-7,100
-19% -$34.2K ﹤0.01% 963
2021
Q2 		$220K Sell
37,900
-1,400
-4% -$8.2K ﹤0.01% 978
2021
Q1 		$276K Sell
39,300
-93,500
-70% -$627K ﹤0.01% 1012
2020
Q4 		$637K Buy
+132,800
New +$672K 0.01% 764
2017
Q2 		– Sell
-5,800
Closed -$369K – 1172
2017
Q1 		$369K Buy
+5,800
New +$353K ﹤0.01% 951

Other funds holding CLVS

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Virginia Retirement Systems's CLVS Position: Q1 2022 in Review

Virginia Retirement Systems sold out of Clovis Oncology, Inc. (CLVS) in Q1 2022, closing a stake of 16,500 shares — an estimated $45 sold.

Virginia Retirement Systems first reported a position in CLVS in Q1 2017 and held it in 6 quarters. The position peaked at $637K in Q4 2020. 153 funds tracked by Wall St. Rank hold CLVS as of Q1 2022.

  • Virginia Retirement Systems reported no remaining Clovis Oncology, Inc. position as of Q1 2022 after selling out during the quarter.
  • Virginia Retirement Systems sold 16,500 Clovis Oncology, Inc. shares in Q1 2022, an estimated $45.
  • Virginia Retirement Systems first reported a position in Clovis Oncology, Inc. in Q1 2017 and held it in 6 quarters.
  • Virginia Retirement Systems's Clovis Oncology, Inc. position peaked at $637K in Q4 2020.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2022.

Based on Virginia Retirement Systems's 13F filing for Q1 2022, filed 21 Apr 2022.